Skip to main content
. 2020 Jul 16;12:5845–5855. doi: 10.2147/CMAR.S248698

Figure 1.

Figure 1

The expression patterns of lncRNA MCM3AP-AS1 in B-NHL patients. (A) The expression levels of MCM3AP-AS1 in lymphoma tissues and corresponding normal lymph node tissues were detected by qRT-PCR. ***P<0.0001. (B) The expression levels of MCM3AP-AS1 in the tumor tissues of stage I/II and stage III/IV of patients. **P<0.01. (C) The fold changes of MCM3AP-AS1 expression level in each patient were measured, with 25 patients were classified as low expression and 16 as high expression. (D) Kaplan-Meier curves of overall survivals and Log rank test of patients with low and high MCM3AP-AS1 expression levels. *P<0.05.